The levels of CSF t‐tau and p‐tau 181 levels in CSF, as well as plasma HDL and LDL from the AD patients were significantly higher than that from the CN group (p < 0.001; p < 0.001; p < 0.001; p = 0.004) (Table 1, Figure 2). Here, MAPT is linked to Alzheimer disease.